LUNG

Pulmonx Corp

• Simply Wall St·2d ago

  Pulmonx Insiders Forfeit On 14% Gains After Selling Stock

• TipRanks·03/12 06:02

  Pulmonx Faces Legal, Regulatory and Financial Risks From Off‑Label Use of Its Products

• NASDAQ·03/06 20:19

  Noteworthy Friday Option Activity: DAL, CVNA, LUNG

• Benzinga·03/06 17:05

  12 Health Care Stocks Moving In Friday's Intraday Session

• TipRanks·03/06 00:05

  Pulmonx Earnings Call: Cost Discipline Amid Growth Pause

• Dow Jones·03/05 20:37

  Pulmonx Is Maintained at Buy by Canaccord Genuity

• Dow Jones·03/05 20:37

  Pulmonx Price Target Cut to $5.00/Share From $6.00 by Canaccord Genuity

• Dow Jones·03/05 14:28

  Pulmonx Is Maintained at Buy by D. Boral Capital

• Dow Jones·03/05 14:28

  Pulmonx Price Target Maintained With a $14.00/Share by D. Boral Capital

• TipRanks·03/05 12:30

  Analysts Offer Insights on Healthcare Companies: Pulmonx (LUNG), Veeva Systems (VEEV) and Theravance Biopharma (TBPH)

• TipRanks·03/05 11:42

  Pulmonx price target lowered to $5 from $6 at Canaccord

• TipRanks·03/05 11:36

  Pulmonx Secures New Term Loan and Issues Warrants

• Seeking Alpha·03/04 23:22

  Pulmonx outlines 2026 revenue target of $90M-$92M with cost realignment and renewed U.S. sales focus

• The Motley Fool·03/04 23:11

  Pulmonx (LUNG) Q4 2025 Earnings Call Transcript

• NASDAQ·03/04 22:35

  Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates